A Phase 2 Influenza A Challenge Study Following Oral Administration of an H1N1 HA Ad-Vector Seasonal Flu Vaccine
Condition:   Influenza Interventions:   Biological: VXA-A1.1;   Biological: Fluzone®;   Other: Placebo Tablets;   Other: Saline Solution for Placebo IM Injection Sponsors:   Vaxart;   Biomedical Advanced Research and Development Authority Recruiting - verified September 2016 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 26, 2016 Category: Research Source Type: clinical trials